News | February 18, 2021
Granules India announces approval of Potassium Chloride ER Capsules
Granules now has a total of 37 ANDA approvals from US FDA (36 Final approvals and 1 tentative approvals).
Granules now has a total of 37 ANDA approvals from US FDA (36 Final approvals and 1 tentative approvals).
The company is expected to conduct further studies to confirm the long-term efficacy and safety of Vijoice in both adult and paediatric patients
The trial will evaluate the efficacy and safety of IPX203 versus immediate-release levodopa/carbidopa
Marks first international filing for Evofem’s single-dose oral treatment
The technology offers scalable continuous granulation at 200 kg/hour, with the potential to exceed 500 kg/hour for certain granules
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
